Lipid mediators produced through the lipoxygenase pathway.
about
Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RIInhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in manRelease of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosisInflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculatureAntibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line.Identification of a negative feedback loop in biological oxidant formation fegulated by 4-hydroxy-2-(E)-nonenalStaphylococcal enterotoxin C1-induced pyrogenic cytokine production in human peripheral blood mononuclear cells is mediated by NADPH oxidase and nuclear factor-kappa B.Effects of fatty acids and dietary lipids on cells of the immune system.Multiple loss of effector cell functions in FcR gamma-deficient mice.First place--resident basic science award 1999. Effects of leukotriene and cyclo-oxygenase inhibition on adaptive bone remodeling in the middle ear.Occurrence of free and esterified lipoxygenase products in leaves of Glechoma hederacea L. and other Labiatae.Role of arachidonic acid in the regulation of the inflammatory response in TNF-alpha-treated rats.Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.Analysis of leukotriene B4 metabolism in human promyelocytic HL-60 cells.Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factor.Global assessment of oxidized free fatty acids in brain reveals an enzymatic predominance to oxidative signaling after trauma.
P2860
Q24675377-DA1717DE-033F-4431-B6A0-650A1E052ED8Q28326803-428F9CC5-8133-4A79-A289-B47F5C53D70EQ35563094-B33C2C6B-77AC-45CA-9D15-2F546695E01BQ36353613-406CD895-C395-425F-BDCB-6F41CFD91E75Q36797899-C09EC870-3020-40A6-9ACE-A8B73A464906Q38976754-99C9C778-06B8-4524-A9D1-3D1BD5CA3D57Q40445480-CD8191F1-E3E1-4E31-9DD5-1BA4FDA0AAECQ41131889-667D2FAD-4E40-46D0-8024-CC8822A74857Q41180664-D4B0F958-8F11-47B2-A80E-91FAE85F919CQ41746348-701C33C5-6300-4AA7-807A-5614174B849AQ42024101-4ACDB0A5-77A1-4554-A4A7-97C664312869Q42461143-426890FE-276E-4035-8977-F951F0CBDA8CQ42560901-C20F1F91-515C-44BD-987C-D2308156A719Q42862841-4312C6F4-0541-4753-8BAD-20EFA8E36A67Q45337763-05BF903A-BFFC-4C74-B0FB-2D10EA6E1657Q46395772-20953129-FC18-436E-B9E1-34E8F6BB004F
P2860
Lipid mediators produced through the lipoxygenase pathway.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Lipid mediators produced through the lipoxygenase pathway.
@en
Lipid mediators produced through the lipoxygenase pathway.
@nl
type
label
Lipid mediators produced through the lipoxygenase pathway.
@en
Lipid mediators produced through the lipoxygenase pathway.
@nl
prefLabel
Lipid mediators produced through the lipoxygenase pathway.
@en
Lipid mediators produced through the lipoxygenase pathway.
@nl
P1476
Lipid mediators produced through the lipoxygenase pathway.
@en
P2093
P356
10.1146/ANNUREV.IY.05.040187.000433
P577
1987-01-01T00:00:00Z